单位:[1]Nosocomial Infection Control Office of China‐Japan Friendship Hospital, Beijing, China[2]Hospital Management Institute, Beijing University of Chinese Medicine, Beijing, China[3]Department of Clinical Microbiology and Infectious Diseases of China‐Japan Friendship Hospital, Beijing, China[4]National Clinical Research Centre of Respiratory Diseases, Centre for Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, China‐Japan Friendship Hospital, Beijing, China[5]Department of Pulmonary Medicine, Capital Medical University, Beijing, China
Introduction China has a very high tuberculosis (TB) burden. The interferon-gamma release assay (IGRA) is more specific for the diagnosis of latent tuberculosis infection (LTBI) than the tuberculin skin test, especially among populations with a high degree of coverage by the BCG vaccine. Objectives Methods To evaluate the first screening of healthcare workers (HCW) for LTBI using the IGRA at a general hospital in Beijing. A pilot screening program for LTBI was triggered by accidental contact between HCW and two patients with active TB in the emergency department (ED). Given the necessity of estimating the overall LTBI prevalence in the institution, a sample of 518 HCW was enrolled in our cross-sectional study. The second IGRA was repeated with 43 of the 121 HCW in the ED after exposure to index TB cases. Data on putative risk factors were collected with a self-administered questionnaire. Results Conclusions The prevalence of LTBI in the targeted population was 21.8%. Differences in the prevalence of LTBI were significantly related to age, employment duration, and history of occupational exposure. A lack of childhood BCG vaccination was independently associated with the prevalence of LTBI (adjusted OR: 1.686, 95% CI: 1.045-2.723, P = .0325). No new LTBI was diagnosed 12 weeks postexposure. No HCW adopted the preventive treatment for LTBI. Considering the high morbidity of LTBI among HCW even in general hospitals, it is essential to formulate government policies and institutional operation protocols for the systematic screening, registration, and administration of prophylaxes for the control of LTBI.
基金:
China-Japan Friendship Hospital; National Science Grant for Distinguished Young Scholars [81425001/H0104]
第一作者单位:[1]Nosocomial Infection Control Office of China‐Japan Friendship Hospital, Beijing, China[2]Hospital Management Institute, Beijing University of Chinese Medicine, Beijing, China
通讯作者:
通讯机构:[1]Nosocomial Infection Control Office of China‐Japan Friendship Hospital, Beijing, China[3]Department of Clinical Microbiology and Infectious Diseases of China‐Japan Friendship Hospital, Beijing, China[4]National Clinical Research Centre of Respiratory Diseases, Centre for Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, China‐Japan Friendship Hospital, Beijing, China[5]Department of Pulmonary Medicine, Capital Medical University, Beijing, China[*1]Respiratory and Critical Department of China‐Japan Friendship Hospital, Yinghua East Street No. 2, Chaoyang District, Beijing 100029, China
推荐引用方式(GB/T 7714):
Guo Li Ping,Jiang Yan,Liu Ying Mei,et al.First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China[J].CLINICAL RESPIRATORY JOURNAL.2018,12(11):2581-2589.doi:10.1111/crj.12960.
APA:
Guo, Li Ping,Jiang, Yan,Liu, Ying Mei&Cao, Bin.(2018).First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China.CLINICAL RESPIRATORY JOURNAL,12,(11)
MLA:
Guo, Li Ping,et al."First assessment of interferon gamma release assay results among healthcare workers at a general hospital in China".CLINICAL RESPIRATORY JOURNAL 12..11(2018):2581-2589